B42.81
Cerebral sporotrichosis
Clinical Classification Guidelines
Inclusion Terms
- Meningitis due to sporotrichosis
Medical Intelligence & Overview
Cerebral sporotrichosis, classified under ICD-10 code B42.81, is a rare form of fungal infection that affects the brain. It is caused by the fungus Sporothrix schenckii, which typically infects the skin but can sometimes spread to the central nervous system leading to meningitis. This condition is uncommon but can be serious if not diagnosed and treated promptly. Recognizing the symptoms and understanding the causes can help in seeking timely medical attention.
Causes & Symptoms
Clinical Causes: Infection with the fungus Sporothrix schenckii, often entered through cuts or wounds on the skin. Spread of the fungus from the skin or lymphatic system to the brain through the bloodstream. Inhalation of spores in environments contaminated with the fungus, especially in individuals with weakened immune systems. In rare cases, dissemination from other infected parts of the body to the brain.
Key Symptoms: Headache that persists or worsens over time. Altered mental state, including confusion or difficulty concentrating. Fever and chills, indicating infection. Neurological deficits such as weakness, numbness, or seizures. Neck stiffness or pain, suggestive of meningitis. Visual disturbances or changes in consciousness.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of cerebral sporotrichosis involves a combination of clinical evaluation and laboratory testing. A healthcare provider may request blood tests to detect fungal markers, imaging tests like MRI or CT scans to observe brain inflammation, and cerebrospinal fluid analysis to identify the presence of the fungus. Sometimes, a brain biopsy may be necessary for definitive diagnosis. It's essential to distinguish this condition from other causes of meningitis to ensure appropriate treatment.
Treatment Protocols: Treatment usually involves antifungal medications prescribed by a healthcare professional. Common antifungal agents include amphotericin B, itraconazole, or flucytosine, often administered over an extended period. Managing symptoms and preventing complications are also crucial aspects of care. Early diagnosis and adherence to treatment protocols significantly improve outcomes, reducing the risk of neurological damage.
Clinical Advice & FAQs
Billing Guidance
Is B42.81 a billable ICD-10 code?
Yes, B42.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B42.81?
Clinical documentation must specify the nature of Cerebral sporotrichosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference